The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Serum glial fibrillary acidic protein as a biomarker for intracerebral haemorrhage in patients with acute stroke
Open accessAbstract
BACKGROUND: Biomarkers of stroke are an evolving field of clinical research. A serum marker which can differentiate between haemorrhagic and ischaemic stroke in the very early phase would help to optimise acute stroke management. OBJECTIVE: To examine whether serum glial fibrillary acidic protein (GFAP) identifies intracerebral haemorrhage (ICH) in acute stroke patients. METHODS: A pilot study assessing 135 stroke patients admitted within six hours after symptom onset. Diagnosis of ICH (n = 42) or ischaemic stroke (n = 93) was based on brain imaging. GFAP was determined from venous blood samples obtained immediately after admission, using a research immunoassay. RESULTS: GFAP was detectable in the serum of 39 patients (34 of 42 (81%) with ICH, and five of 93 (5%) with ischaemic stroke). Serum GFAP was substantially raised in patients with ICH (median 11 ng/l, range 0 to 3096 ng/l) compared with patients with ischaemic stroke (median 0 ng/l, range 0 to 14 ng/l, p<0.001). Using receiver operating characteristic curve analysis, a cut off point of 2.9 ng/l provided a sensitivity of 0.79 and a specificity of 0.98 for the identification of ICH in acute stroke (positive predictive value 0.94, negative predictive value 0.91; p<0.001). CONCLUSIONS: Serum GFAP can reliably detect ICH in the acute phase of stroke. Further evaluation of the usefulness of GFAP as an early diagnostic marker of ICH is now required, with the aim of optimising cause specific emergency management.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Spontaneous intracerebral hemorrhage
Qureshi, A. I., Tuhrim, S., Broderick, J. P., Batjer, H. H., Hondo, H., & Hanley, D. F. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105103441907 · Cited by 1,719
Cited by
Glial fibrillary acidic protein: From intermediate filament assembly and gliosis to neurobiomarker
Yang, Z., & Wang, K. K. W. (2015) · Trends in Neurosciences · doi:10.1016/j.tins.2015.04.003 · Cited by 1,050
Blood GFAP as an emerging biomarker in brain and spinal cord disorders
Abdelhak, A., Foschi, M., Abu-Rumeileh, S., Yue, J. K., D’Anna, L., Huss, A., Oeckl, P., Ludolph, A. C., Kuhle, J., Petzold, A., et al. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-021-00616-3 · Cited by 807
GFAP and S100B are biomarkers of traumatic brain injury: An observational cohort study
Vos, P. E., Jacobs, B., Andriessen, T. M. J. C., Lamers, K. J. B., Borm, G. F., Beems, T., Edwards, M., Rosmalen, C. F., & Vissers, J. L. M. (2010) · Neurology · doi:10.1212/wnl.0b013e3181fd62d2 · Cited by 367
Stroke Biomarkers: Progress and Challenges for Diagnosis, Prognosis, Differentiation, and Treatment
Saenger, A. K., & Christenson, R. H. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2009.133801 · Cited by 252
Huang, W., Besar, K., LeCover, R., Dulloor, P., Sinha, J., Martínez Hardigree, J. F., Pick, C., Swavola, J., Everett, A. D., Frechette, J., et al. (2014) · Chem. Sci. · doi:10.1039/c3sc52638k · Cited by 83
Metadata
- Authors
- Foerch, C.
- Venue
- Journal of Neurology, Neurosurgery & Psychiatry
- Publisher
- BMJ
- Published
- 2006-02-01
- Volume
- 77
- Issue
- 2
- Pages
- 181-184
- ISSN
- 0022-3050 (ISSN-L)
- OpenAlex
- W2100949962
- Cited by
- 201
- References
- 1
- FWCI
- 2.82
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Serum glial fibrillary acidic protein as a biomarker for intracerebral haemorrhage in patients with acute stroke. https://app.cochat.ai/papers/10.1136/jnnp.2005.074823
- The paper
- Foerch, C. (2006). Serum glial fibrillary acidic protein as a biomarker for intracerebral haemorrhage in patients with acute stroke. Journal of Neurology, Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.2005.074823
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.